🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementPancreatitis risk assessment — March 2026

Pancreatitis risk assessment — March 2026

sarah.morrison Fri, Mar 6, 2026 at 3:33 AM 9 replies 740 viewsPage 1 of 2
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Mar 6, 2026 at 3:33 AM#1

I had a scare that turned out not to be pancreatitis, and the useful thing I took from it was how specific the presentation actually is.

The narrow version of the question is what the pooled safety data actually shows for this class, as opposed to what the label warning implies.

Tell me what I have not thought of.

45 15josh_phd_bmore, roxy_nash, tony_orlando and 42 others
Reply Quote Save Share Report
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
Mar 6, 2026 at 4:01 AM#2
sarah.morrison said:
I had a scare that turned out not to be pancreatitis, and the useful thing I took from it was how specific the presentation actually is.

Pancreatitis scare with pancreatitis risk: had severe upper abdominal pain radiating to my back at week 11. Went to the ER — they checked lipase and amylase, both normal. Turned out to be a gallstone.

But I'm glad I went. The risk of pancreatitis, while small (<0.5%), is real. Don't try to tough out severe abdominal pain on a GLP-1 agonist. Get checked.

44 14mark_tokyo, hans_munich, jason_sac26 and 41 others
Reply Quote Save Share Report
jason_paloalto
Member
212
890
Nov 2024
Palo Alto, CA
Mar 6, 2026 at 4:29 AM#3
julia.endo said:
Pancreatitis scare with pancreatitis risk: had severe upper abdominal pain radiating to my back at week 11.

Lipase monitoring while on pancreatitis risk: my doctor checks lipase every 3 months given the theoretical pancreatitis risk. All readings have been normal:

  • Baseline: 43 U/L
  • Month 3: 41 U/L
  • Month 6: 31 U/L
  • Month 9: 43 U/L

Normal range is 0-160 U/L. While clinical pancreatitis is rare (<0.5%), I find peace of mind in regular monitoring. Worth asking your doctor about if you're on a GLP-1 long-term.

Last edited: Mar 6, 2026 at 9:29 AM
43 13mona_PHX, andrew_nyc, Dr.EndoEP and 40 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
DoseLogDan
Member
201
567
Feb 2025
Montana
Mar 6, 2026 at 4:57 AM#4
sarah.morrison said:
I had a scare that turned out not to be pancreatitis, and the useful thing I took from it was how specific the presentation actually is.

Second this. Posting only so the count is not one.

42 12sophie_paris, mel_PDX, Dr.AddMedPHL and 39 others
Reply Quote Save Share Report
Dr.RheumBOS
Member
567
2,345
Apr 2024
Boston, MA
Mar 6, 2026 at 7:30 AM#5

Adding the clinical framing, because it changes how the question reads. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

41 11Dr.PulmRoch, maya_sedona, stefan_berlin and 38 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register